{"id":48071,"date":"2022-09-07T18:01:59","date_gmt":"2022-09-07T16:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/"},"modified":"2022-09-07T18:01:59","modified_gmt":"2022-09-07T16:01:59","slug":"applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/","title":{"rendered":"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022"},"content":{"rendered":"
\n

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN<\/a> #LinearDNA<\/a>—Applied DNA Sciences, Inc.<\/a> (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th<\/sup> Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference is being held as a hybrid in-person\/virtual event from September 12 to 14, 2022.\n<\/p>\n

<\/a><\/p>\n

\nApplied DNA\u2019s CEO and Chairman of the Board of Directors, Dr. James A. Hayward, will present in person and provide an overview of the Company\u2019s business during the presentation.\n<\/p>\n

\nTo listen to a livestream of the Company\u2019s presentation, please click on the following link to register for the conference: Applied DNA presentation at the H.C. Wainwright 24th<\/sup> Annual Global Investment Conference<\/a>\n<\/p>\n

\nEvent:<\/b> H.C. Wainwright 24th Annual Global Investment Conference (Hybrid Conference)\n<\/p>\n

\nDate:<\/b> September 13, 2022\n<\/p>\n

\nTime:<\/b> 2:00 pm Eastern Time\n<\/p>\n

\nLocation:<\/b> In-person at the Lotte New York Palace Hotel, New York, NY.\n<\/p>\n

\nNote: <\/b>To schedule a one-on-one with management, please get in touch with your H.C. Wainwright representative.\n<\/p>\n

\nAbout Applied DNA Sciences<\/b>\n<\/p>\n

\nApplied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (\u201cDNA\u201d). Using PCR to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.\n<\/p>\n

\nVisit adnas.com <\/a>for more information. Follow us on Twitter<\/a> and LinkedIn<\/a>. Join our mailing list<\/a>.\n<\/p>\n

\nThe Company\u2019s common stock is listed on NASDAQ under the ticker symbol \u2018APDN,\u2019 and its publicly traded warrants are listed on OTC under the ticker symbol \u2018APPDW.\u2019\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Contact: <\/b>Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com<\/a>
Web:<\/b> www.adnas.com<\/a>
Twitter: <\/b>@APDN\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference is being held as … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48071","6":"format-standard","7":"category-industry"},"yoast_head":"\nApplied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference is being held as ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T16:01:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220907005997\/en\/593924\/21\/box-logo-businesswire.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022\",\"datePublished\":\"2022-09-07T16:01:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/\"},\"wordCount\":329,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005997\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/\",\"name\":\"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005997\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\",\"datePublished\":\"2022-09-07T16:01:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005997\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005997\\\/en\\\/593924\\\/21\\\/box-logo-businesswire.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/","og_locale":"en_US","og_type":"article","og_title":"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Pharma Trend","og_description":"STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the \u201cCompany\u201d), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference is being held as ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-07T16:01:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220907005997\/en\/593924\/21\/box-logo-businesswire.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022","datePublished":"2022-09-07T16:01:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/"},"wordCount":329,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907005997\/en\/593924\/21\/box-logo-businesswire.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/","url":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/","name":"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907005997\/en\/593924\/21\/box-logo-businesswire.jpg","datePublished":"2022-09-07T16:01:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220907005997\/en\/593924\/21\/box-logo-businesswire.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220907005997\/en\/593924\/21\/box-logo-businesswire.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/applied-dna-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference-september-12-14-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48071"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48071\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}